Spots Global Cancer Trial Database for granulocyte colony stimulating factor
Every month we try and update this database with for granulocyte colony stimulating factor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) | NCT00231309 | Hematologic Dis... Hematologic Mal... | Granulocyte Col... | - 55 Years | Emory University | |
| Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations | NCT00943943 | Acute Myelogeno... Leukemia | G-CSF Plerixafor Sorafenib | 18 Years - | M.D. Anderson Cancer Center | |
| Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support | NCT00506857 | Hematologic Mal... | Busulfan Fludarabine | - 75 Years | M.D. Anderson Cancer Center | |
| Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support | NCT00506857 | Hematologic Mal... | Busulfan Fludarabine | - 75 Years | M.D. Anderson Cancer Center | |
| High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | NCT01526603 | Neuroblastoma | Carboplatin Autologous stem... Granulocyte col... Radiation thera... Isotretinoin (1... Melphalan Etoposide | - 30 Years | Masonic Cancer Center, University of Minnesota | |
| Multi-level Evaluation of Chemotherapy-induced Febrile Neutropenia Prophylaxis, Outcomes, and Determinants With Granulocyte-colony Stimulating Factor | NCT01459653 | Febrile Neutrop... Cancer Breast Cancer Ovarian Cancer Lung Cancer Prostate Cancer Multiple Myelom... Bladder Cancer B-cell Lymphoma | 18 Years - | Sandoz | ||
| DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess | NCT03356080 | Acute Myeloid L... Myelodysplastic... | Decitabine Cytarabine All-transretino... G-CSF | 18 Years - 90 Years | Shanghai Tong Ren Hospital | |
| Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma | NCT02605421 | Neuroblastoma | Thiotepa Cyclophosphamid... Melphalan Etoposide Carboplatin Autologous Stem... Granulocyte col... | - 30 Years | Masonic Cancer Center, University of Minnesota | |
| Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 Mutations | NCT00943943 | Acute Myelogeno... Leukemia | G-CSF Plerixafor Sorafenib | 18 Years - | M.D. Anderson Cancer Center | |
| High Dose Chemotherapy and Autologous Transplant for Neuroblastoma | NCT01526603 | Neuroblastoma | Carboplatin Autologous stem... Granulocyte col... Radiation thera... Isotretinoin (1... Melphalan Etoposide | - 30 Years | Masonic Cancer Center, University of Minnesota | |
| G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome | NCT00228813 | Hematologic Mal... | Granulocyte Col... | - 22 Years | Emory University | |
| DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess | NCT03356080 | Acute Myeloid L... Myelodysplastic... | Decitabine Cytarabine All-transretino... G-CSF | 18 Years - 90 Years | Shanghai Tong Ren Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
